The novel treatment of the medication represents a significant advance in the care of type 2 diabetes. Different to existing medications, tirzepatide impacts dual pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatidepeptide119745.ampedpages.com/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment-69055275